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Summary 
Our aim was to prospectively determine the predictive capabilities of SEPSIS-1 
and SEPSIS-3 definitions in the Emergency Departments and general wards.  
Patients with National Early Warning Score of 3 or above and suspected or 
proven infection were enrolled over a 24-hour period in 13 Welsh hospitals. 
Primary outcome was mortality within 30 days. 
Out of the 5422 patients screened, 431 fulfilled inclusion criteria and 380 (88%) 
were recruited. Using the SEPSIS-1 definition 212 patients had sepsis. Using the 
SEPSIS-3 definitions with Sequential Organ Failure Assessment score ≥2, 272 
patients, with quickSOFA score ≥2, 50 patients were identified. For the prediction 
of primary outcome SEPSIS-1 criteria had a sensitivity (95%CI) 65% (54%-75%) 
and specificity (95%CI) 47% (41%-53%), SEPSIS-3 criteria had a sensitivity 
(95%CI) 86% (76%-92%) and specificity (95%CI)  32% (27%-38%). SEPSIS-3 
and SEPSIS-1 definitions were associated with an HR of 2.7 (95% CI, 1.5-5.6) 
and HR of 1.6 (95% CI, 1.3-2.5), respectively. Scoring system discrimination 
evaluated by receiver operating characteristic curves was highest for Sequential 
Organ Failure Assessment score  (0.69 [95% CI 0.63-0.76]), followed by National 
Early Warning Score (0.58 [0.51-0.66]) (p-value <0.001). Systemic Inflammatory 
Response Syndrome criteria (0.55 [95%CI 0.49-0.61]) and quickSOFA score 
(0.56 [95%CI 0.49-0.64]) could not predict outcome. SEPSIS-3 definition 
identified patients with the highest risk. Sequential Organ Failure Assessment 
score and National Early Warning Score were better predictors of poor outcome. 
 4 
Sequential Organ Failure Assessment score appeared to be the best tool for 
identifying patients with high risk of death and sepsis induced organ dysfunction. 
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Introduction 
Sepsis is defined as dysregulated host response to infection, resulting in acute 
organ dysfunction [1]. While the condition has been thoroughly studied in the 
Intensive Care Unit (ICU), accurate data collection outside of this setting is less 
well-developed. It is thought however that the number of cases in the wider 
hospital is far higher [2-4]. In the UK, anaesthetists and critical care practitioners 
have been at the forefront of developing effective systems to identify and treat 
patients with sepsis outside the critical care areas. They identified a clear need to 
understand the significance of the condition in the pre-ICU environment and the 
tools we might use to identify and treat those most at risk [5].  
 
We previously reported the results of a point prevalence feasibility study and 
subsequent study of all Welsh centres using the 1992 International Consensus 
Criteria for sepsis (SEPSIS-1) utilsing electronic data collection and real-time 
data monitoring [6-8] We found that four percent of hospitalised patients had 
sepsis, half of whom had significant organ dysfunction (severe sepsis). Strikingly, 
the 90-day mortality among the whole hospital cohort was in excess of 30% for 
sepsis and almost 40% for severe sepsis [7].  
 
Concurrently, the validity and clinical utility of the existing sepsis definitions, 
which were previously based on the concept of systemic inflammatory response 
syndrome (SIRS) were questioned [9]. The 3rd International Consensus 
Definitions for sepsis (SEPSIS-3) have recently been published, with significantly 
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revised clinical criteria, including the use of Sequential Organ Failure 
Assessment (SOFA) scores and the quick SOFA (qSOFA) screening tool for 
non-ICU settings [1, 10]. During the development phase, most of the datasets 
used were from North America including variable proportions of non-ICU patients 
[10]. It is not known how the new SEPSIS-3 definitions would perform compared 
with SEPSIS-1 definitions in identifying patients at risk with sepsis in a UK ward 
setting, and furthermore how they might perform compared with a well-
established track and trigger tool, the National Early Warning Score (NEWS) [11, 
12].  
 
Our objectives were to determine the ability of the SEPSIS-1 definition using the 
SIRS criteria, the SEPSIS-3 definition using SOFA and qSOFA scores and the 
NEWS track and trigger tool to predict outcome outside of the ICU. 
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Methods  
This multi-centre, prospective, observational study of patients with suspected 
sepsis in 13 hospitals in Wales was approved by the South Wales Regional 
Ethics Committee (16/WA/0071) and patients or their proxy in case of patients 
lacking capacity gave written informed consent. We enrolled consecutive patients 
presenting to hospitals in Wales with 24/7 consultant-level Emergency 
Department (ED) supervision and the facility to admit and treat any acutely 
unwell patient. We screened patients in.the ED or in an acute in-patient ward 
setting with suspected or proven infection on 19th October 2016, Wednesday 
(0800 to 0759 hours the following day). This date represented a typically 
“average” day in the NHS [13,14]. We approached all patients with NEWS≥3 in 
whom the treating clinical teams had a high clinical suspicion of an infection 
(documented as such in the medical or nursing notes) and following consent we 
screened for presence of sepsis either using SEPSIS-1 or SEPSIS-3 definitions.  
We excluded patients if they were less than 18 years of age or if they were 
already on intensive care or high dependency units. We referred patients to the 
clinical teams if the medical student data collectors felt they needed urgent 
medical attention due to their condition, in line with the requirements of the Ethics 
approval. To facilitate linkage to national databases for the collection of follow-up 
data, we collected patient identifiable data and entered on to the secure data 
collection tool.  
 
We defined sepsis as presence or strong suspicion of infection together with 2 or 
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more SIRS criteria according to the SEPSIS-1 definition or as presence or strong 
suspicion of infection together with SOFA score 2 or above, or qSOFA score 2 or 
above according to the SEPSIS-3 definition. We used SIRS criteria as 
(respiratory rate greater than 20 breaths per minute, temperature greater than 
38° C or less than 36° C, heart rate greater than 90 beats per minute, and white 
blood cell count greater than 12,000/mm3, less than 4,000/mm3, or greater than 
10% bands) [6]. We defined qSOFA scores as systolic blood pressure ≤100mm 
Hg, respiratory rate ≥22 breaths per minute, and altered mental status (defined 
as either a Glasgow Coma Scale score ≤13 or an Alert Voice Pain Unresponsive 
scale (AVPU) other than “Alert”) [10]. We calculated SOFA and NEWS scores 
based on previously published tables [11, 15]. 
To calculate SOFA scores and determine organ dysfunction according to the 
SEPSIS-1 definition, we used laboratory values within 24 hours of study 
enrolment, and if no prior values were available a median (normal) value was 
imputed, as per prior studies [3, 10, 16]. Most patients did not have an arterial 
blood gas available at time of observation, so to calculate the respiratory 
component of the SOFA score, we followed the algorithm developed and 
validated by Pandharipande and colleagues [16]. We defined infection related 
acute organ dysfunction according to the SEPSIS-1 criteria as any of the 
following present: systolic BP <90 mmHg or MAP < 65 mmHg or lactate > 2.0 
mmol/L (after initial fluid challenge), INR >1.5 or aPTT >60 s, Bilirubin >34 
µmol/L, Urine output <0.5 mL/kg/h for 2 h, Creatinine >177 µmol/L, Platelets 
<100 ×109/L, PaO2/FiO2 ratio below 250, or as SOFA score 2 or above 
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according to the SEPSIS-3 definition [1, 6]. We recorded the NEWS score on 
study entry and we noted if this was the worst value in the preceding 24-hour 
period. [10, 15]  
Data collectors, working in pairs to ensure data validity and appropriate clinical 
knowledge, were supported by continuous online web-chat. This ensured that 
senior clinicians identified through the Welsh Intensive Care Society Audit and 
Research Group and three study coordinators were available throughout the trial 
period.  We provided key study information through e-mails, face-to-face training 
and online video tutorials, which included the protocol, answers to key questions 
and description of the electronic case report form (eCRF) on the electronic 
tablets. We previously published the details of the digital data collection platform 
developed for this study [8].  
We collected data from medical and nursing records, including demographic data, 
baseline co-morbidity and frailty (according to the Dalhousie Clinical Frailty 
Scale), physiological and laboratory values and process measures (such as 
critical care involvement and completion of sepsis care bundles) [17]. We 
followed up patients until 30 days after study enrolment.  
Outcomes 
The primary outcome was mortality within 30 days of recruitment. Secondary 
outcome was presence of organ dysfunction defined by SOFA score >2 or 
presence of “severe sepsis” according to the SEPSIS-1 definition [10, 18]. 
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Statistical analysis: 
Categorical variables are described as proportions and are compared using chi-
square or Fisher’s exact test. Comparisons of continuous variables are 
performed using one-way ANOVA or Mann-Whitney test as appropriate.  
To assess the performances of the SEPSIS-1 and SEPSIS-3 definitions to 
predict the primary end point, we calculated diagnostic performances (sensitivity, 
specificity, negative and positive predictive values). We constructed a receiver 
operating characteristic (ROC) curve and calculated the corresponding area 
under the ROC curve (AUROC). We plotted Kaplan-Meier survival curves and 
compared time-to-event data using log-rank test. We estimated the respective 
hazard ratios (HRs) for the primary outcome within 30 days of SEPSIS-1 and 
SEPSIS-3 definitions with a Cox proportional hazards model after adjustment for 
measured confounders. The model fit was assessed by the -2 log likelihood 
statistics and Chi-square test. All statistical tests were calculated using SPSS 
20.0 (SPSS Inc., Chicago, IL). A two-tailed p-value <0.05 was considered 
statistically significant.  
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Results:  
 
There were 5422 in-patients in the 24-hour study period in the 13 participating 
hospitals (Fig 1). 431 patients had NEWS≥3 and documented clinical suspicion 
of infection and all were approached for recruitment. Sixty-four patients (16.8%) 
were recruited in the ED, the others in a variety of ward-based environments. 
Baseline characteristics are summarised in Table 1.  
 
We identified 212 patients having sepsis using the SEPSIS-1 definition, and 272 
patients using the SEPSIS-3 definition with SOFA≥2 (Fig 2)., Using the qSOFA, 
50 fulfilled the definition criteria (Fig 2). Out of the cohort of 380 patients, 44 
fulfilled neither the SEPSIS-1 nor the SEPSIS-3 criteria (Fig 2). We present the 
characteristics of these groups and secondary outcomes in Online resource 
Table 1. Sepsis related organ dysfunction (“severe sepsis”) was present in 124 
out of 212 patients (58.5%) according to SEPSIS-1 criteria. 99/124 (79.8%) 
patients had SOFA≥2 and 24/124 (19.4%) had qSOFA≥2.  
Out of the 272 patients with sepsis using the SEPSIS-3 definition, 183 (67.3%) 
fulfilled “severe sepsis” criteria. 232/272 (85.3%) of patients had SOFA≥2 using 
only basic physiological (respiratory, cardiovascular and neurological) 
parameters.  
 
SEPSIS-1 and SEPSIS-3 definitions identified various proportions of the 78/380 
(20.5%) patients who died within 30 days (Fig 3). We found a statistically 
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significant difference in the survival of patients described by the SEPSIS-1 and 
SEPSIS-3 definitions or meeting both criteria (Fig 4).  
 
We report the predictive performances of SEPSIS-1 and SEPSIS-3 definitions in 
Table 2 and Online resource Fig 1. 
After adjustment for age and presence of heart failure and using a Cox model, 
we found that the SEPSIS-3 definition was associated with death with an HR of 
2.7 (95% CI, 1.5-5.6). The previous SEPSIS-1 definition had an HR of 1.6 (95% 
CI, 1.03-2.5). 
 
Scoring system discrimination for the primary outcome was highest for SOFA 
(AUROC 0.70 [95% CI 0.63-0.77], p<0.001), followed by NEWS (AUROC 0.59 
[0.51-0.66], p=0.02) Positive likelihood ratio was 1.27 (95%CI 1.13-1.43) for 
SOFA and 1.48 (95%CI 1.02-2.16) for NEWS. Negative predictive value for 
SOFA was 89% (95%CI, 81%-94%) and for NEWS 73% (95% CI, 67%-77%).  
SIRS (AUROC 0.55 [95%CI 0.48-0.62]) and qSOFA score (AUROC 0.57 [95%CI 
0.49-0.64]) could not statistically predict outcome in this patient population 
(p=0.21 and 0.07 for SIRS and qSOFA, respectively). We report the predictive 
capabilities of qSOFA≥2, severe sepsis criteria defined by the SEPSIS-1 
definition and NEWS≥6 in Table 2. 
 
Prognostic performances of SOFA, qSOFA, SIRS and NEWS to predict acute 
organ dysfunction are reported in Online resource Table 2 and Online resource 
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Fig 2. SOFA was the best predictive model (AUROC 0.950 [95%CI 0.930-0.971], 
p<0.001), followed by NEWS (AUROC 0.694 [95%CI 0.634-0.754], p<0.001), 
qSOFA (AUROC 0.668 [95%CI 0.606-0.730], p<0.001) and SIRS (AUROC 0.580 
[95%CI 0.514-0.647], p=0.029).  
Fifty-nine patients (15.5%) were screened for sepsis using the official All Wales 
sepsis screening tool. Sepsis-6 bundle was completed in 44 occasions (11.6%), 
Critical care outreach was involved in 33 cases (8.7%).  Intravenous antibiotics 
were administered either as a mono- or a combination-therapy to 220 (57.9%) 
patients. 
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Discussion: 
 
To our knowledge this is the first prospective evaluation of the diagnostic and 
predictive capability of SEPSIS-1 versus SEPSIS-3 criteria in the UK. There was 
considerable overlap between them, SEPSIS-3 covering larger proportion of 
patients at risk. However, 63 (16.6%) patients - 12 of them falling into the 
previous “severe sepsis” category - would have been missed by applying only the 
new SEPSIS-3 definitions. On the other hand, application of SIRS-based criteria 
(SEPSIS-1) excluded 105 (27.3%) patients, all of whom had evidence of acute 
organ dysfunction.  
 
Our results add further to the debate about the clinical usefulness of the qSOFA 
score, which was developed as an easy to use prediction tool for identifying 
patients at risk in the sepsis population [10]. There is an ongoing controversy 
surrounding the utility and efficacy of qSOFA in the prehospital, ED and general 
ward setting [20-24]. We found that using only the qSOFA score 50 [13.2%) 
patients would have been diagnosed with sepsis, missing 116 (30.5%) patients 
with organ dysfunction. In contrast to the results of Seymour and coworkers, 
qSOFA also failed to predict outcome at 30 days and did not offer any predictive 
value over the SOFA and NEWS scores for ability to predict infection induced 
acute organ failure in this patient population [10]. We found a striking disconnect 
between SOFA and qSOFA scores. Whilst our sample size is too small to draw 
firm conclusions, we have seen that the biggest discrepancy was between the 
 15 
respiratory element of SOFA and qSOFA scores (data not shown). It is possible 
that the SpO2/FiO2 ratio used in our study is a much more sensitive parameter to 
indicate respiratory compromise, than the high respiratory rate in the qSOFA 
system. Our results warrant careful interpretation, as our sample size was orders 
of magnitude smaller compared to the original qSOFA study [10]. 
In their large dataset of non-ICU patients, median (IQR) SOFA was 1 (2), with 
significantly lower hospital mortality of 3% indicating a population at lower risk 
compared to ours. Interestingly, in their ICU cohort with a mortality of 17%, the 
AUROC of qSOFA at 0.66 (95%CI 0.64-0.68) was only slightly better than we 
have observed. Similarly, Raith and colleagues could not confirm the findings of 
the original paper in a patient population where the baseline risk was significantly 
higher with a hospital mortality of 18.7% with AUROC 0.607 (99%CI 0.603-0.611) 
[19]. These data suggest that qSOFA might not be a valuable tool to predict 
outcome in populations where the baseline risk of death is higher than 15%. 
 
Our findings could support the use of SOFA scores even in a resource-limited 
ward setting, though it is unclear how this might best be integrated into already 
established track-and-trigger systems [10, 20, 23, 25, 26]. Donnelly and 
colleagues were able to show in a population based study that high admission 
SOFA was the best tool predict poor outcome in the hospital and within 1 year 
after discharge, with similar AUROC: 0.765 and HR: 2.43 (95%CI 1.84-3.21) to 
ours [25]. From these emerging data it is clear that SIRS based classification of 
sepsis is inferior compared to SOFA for delineating patient cohorts at highest risk 
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of poor outcome [1, 23, 25]. The exact cut-off for SOFA might need further 
recalibration, however the current threshold of 2 or more could be used in the 
vast majority of patients, by calculating the SOFA score from physiological 
parameters readily available at the bedside. 
The high specificity and positive predictive value of NEWS≥6 for acute organ 
dysfunction and adverse outcome underlines the utility and importance of the 
current escalation protocol (“NEWS Six=Sick”) in our health care system [27]. 
Similar to our data, NEWS≥7 was found as the best cut-off for predicting poor 
outcome in a large retrospective cohort of patients with sepsis [24]. Recently a 
multi-centre Scottish study also found that NEWS≥6 carried an increased risk of 
death and ICU admission in patients admitted to the ED with sepsis [28].  
Sepsis either defined by the SEPSIS-1 or SEPSIS-3 criteria had a high mortality: 
22.9% of the patients died within 30 days, significantly higher than the 2.2% 
mortality observed in the group which did not fulfill either criteria for the diagnosis 
of sepsis. This was almost identical to the 22% 30-day mortality observed in our 
previous study, but significantly higher than the 6% and 8% mortality observed in 
the recent studies involving ED and ward patients [7, 20, 24]. This could probably 
be explained by methodological differences between studies. Churpek and 
colleagues used a retrospective dataset, with wider screening criteria more likely 
to capture patients with lower acuity [24]. In fact, only 28% of their 30677 patients 
met severe sepsis definition and the mortality of this subset is not reported [24]. 
With a focus on the ED, only 20% of patients in Freund's study met the SEPSIS-
3 definition and the mortality rate is not available for this cohort [20]. In our 
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dataset, mortality was highest when patients met both SEPSIS-1 and SEPSIS-3 
definitions, highlighting the high risk of death when infection causes end-organ 
dysfunction [1, 9]. On the other hand, the recent PROMISE trial in the UK 
recruiting patients with severe sepsis and septic shock according to the SEPSIS-
1 definition reported 24.5% mortality at 28 days in the control arm, where patient 
characteristics were similar to our study [29]. We included all patients regardless 
of their “do not attempt resuscitation” status or limitation of treatment to certain 
levels and this could have affected mortality rates in our study. 
Our results highlight the need for a simple, fast assessment tool to highlight 
patients on the general wards with sepsis. In the UK, anaesthetists, who will use 
more sophisticated clinical tools, will see many of these patients for further 
evaluation, but enabling the ward staff to streamline these referrals is crucial to 
improve processes of care. 
The strengths of our work include the use of robust, previously published data 
collection methodology tested over subsequent studies and the wide participation 
of centres [7, 8]. We prospectively collected data on patients where the clinical 
teams suspected infection, hence we were able to test the real life utility of the 
new sepsis definition and proposed clinical tools and compare its performance 
with the already implemented SEPSIS-1 criteria. Our study has high internal 
validity as in our subsequent trials using similar methodology we recruited similar 
number of patients with almost identical outcomes in the same hospitals [7, 30].  
 
Our study has some limitations. First, our dataset was a compromise between 
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being an exhaustive list of possible determinants of sepsis using different 
definitions, and being small enough to maintain data collector participation and 
data reliability. Second, we followed our patients up for only 30 days and did not 
collect data on cause of death. Long-term quality of life survey and health-care 
utilisation will be taken forward as part of a longitudinal study. Third, based on 
the findings of others, it is possible that we could also have missed patients with 
sepsis, who had NEWS below 3 (e.g. patients high temperature and white cell 
count, but normal respiratory rate and heart rate) [24, 31]. However, recent data 
suggests that NEWS≥3 may be the best trigger to screen patients for sepsis in 
the ED [32]. Fourth, laboratory elements of the SOFA score were missing in a 
number of patients: serum bilirubin in 36.3%, serum creatinine in 7.9% and 
platelet count in 6.3% of the cases. It is possible that due these omissions the 
number of patients with sepsis according to the SEPSIS-3 criteria is 
underrepresented in our sample. Similarly, only 33.7% of patients had their 
lactate measured, possibly resulting in misrepresentation of the severe sepsis 
category. 
In conclusion, SEPSIS-3 definition identified patients with the highest risk if the 
full SOFA score was used, however there was a considerable overlap between 
the patients identified by the two definitions. SOFA and NEWS were found to be 
better predictors of poor outcome than qSOFA or SIRS in our population. These 
findings will have important implications for clinicians at the bedside and for 
organisations trying to improve the quality of sepsis care. For healthcare systems 
with established track-and-trigger mechanisms, the optimal approach to 
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integrating the new sepsis screening criteria with pre-existing escalation tools is 
yet to be determined. 
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Table 1. Baseline characteristics of the patients in the whole cohort and 
comparing the survivors to those who died within 30 days. 
 All patients 
(n=380) 
Patients 
who died 
(n=78) 
Survivors 
(n=302) 
p-value 
Sex     
Men 180 (47%) 46 (59%) 134 (44%) 0.019 
Women 200 (53%) 32 (41%) 168 (56%) 
Age, year 74 (22 
[82]) 
77 (17 [78]) 73 (22 
[78]) 
0.001 
Systolic blood 
pressure, 
mmHg 
113 (37 
[169]) 
113 (36 
[163]) 
112 (37 
[146]) 
0.192 
Respiratory 
rate, 
breaths/minute 
20 (4 [27]) 20 (5 [19]) 20 (4 [27]) 0.157 
Heart rate,  
beats/minute 
94 (25 
[180] 
95 (24 
[123]) 
93 (24 
[180]) 
0.665 
Glasgow 
Coma Scale 
<15  
51 (13%) 21 (25%) 30 (10%) 0.036 
Temperature, 
Celsius 
36.6 (1.2 
[5.4]) 
36.5 (1.3 
[4.4]) 
36.8 (1.2 
[5.3]) 
0.142 
AVPU<Alert,  20 (5%) 10 (12%) 10 (3%) 0.009 
Clinical signs 
of infection 
    
Cough 176 (46%) 42 (53%) 134 (44%) 0.485 
Dysuria 39 (10%) 10 (13%) 29 (10%) 0.583 
Abdominal 
pain 
68 (18%) 17 (22%) 51 (17%) 0.443 
Headache 20 (5%) 1 (1%) 19 (6%) 0.135 
Other 162 (55%) 34 (44%) 128 (42%) 0.871 
Laboratory 
results 
    
White blood 
cell count, 
cells/mL 
11250 
(6900 
[56000]) 
11700 
(8900 
[43700]) 
11200 
(6300 
[56000]) 
0.304 
Platelet count, 
1000/mL 
269 (161 
[920])* 
223 (230 
[866]) 
274 (150 
[920]) 
0.051 
Creatinine, 
micromol/L 
76 (47 
[671])* 
89 (73 
[650]) 
75 (39 
[588]) 
0.085 
Bilirubin 
micromol/L 
10 (10 
[570])* 
14 (21 
[339]) 
10 (9 
[570]) 
0.022 
Lactate 1.5 (2.0 1.8 (2.0 1.5 (1.0 0.468 
 28 
mmol/L [7.4])* [7.4]) [1.8]) 
Clinical frailty 
score 
5 (3 [8]) 4 (3 [7]) 6 (3 [8]) 0.001 
SIRS     
0 20 (5%) 4 (5%) 16 (5%)  
 
0.402 
1 116 (31%) 18 (23%) 98 (32%) 
2 127 (33%) 28 (36%) 99 (33%) 
3 92 (24%) 24 (31%) 68 (22%) 
4 25 (7%) 4 (5%) 21 (7%) 
qSOFA     
0 152 (40%) 27 (34%) 125 (41%)  
0.042 1 177 (47%) 33 (42%) 144 (48%) 
2 43 (11%) 15 (19%) 29 (10%) 
3 7 (2%) 3 (4%) 4 (1%) 
SOFA 2 (3 [10]) 4 (3 [10]) 2 (2 [9]) <0.001 
SOFA≥2     
No 108 (28%) 10 (13%) 98 (32%) <0.001 
Yes 272 (72%) 67 (86%) 205 (67%) 
NEWS 4 (3 [12]) 5 (4 [12]) 4 (3 [9]) 0.017 
NEWS≥6     
No 265 (70%) 46 (59%) 219 (73%) 0.027 
Yes 115 (30%) 32 (41%) 83 (27%) 
 
Values are N (%) for categorical variables or median (IQR [range]) for continuous 
variables. * Data unavailable in 36.3% (serum bilirubin), 7.9% (serum creatinine), 
6.3% (platelet count) and 66.3% (serum lactate) cases 
AVPU: Alert/Verbal response/Response to pain/Unresponsive; SIRS: systemic 
inflammatory response syndrome; qSOFA: quick Sequential Organ Failure 
Assessment score; SOFA: Sequential Organ Failure Assessment score; NEWS: 
National Early Warning Score 
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Table 2. Diagnostic performances of different sepsis definitions and clinical tools 
for the prediction of mortality at 30 days 
 
SEPSIS-1: 1992 definition of sepsis criteria as defined by Bone et al. (6); 
SEPSIS-3: Third International Consensus Definition of sepsis criteria (1); qSOFA: 
quick Sequential Organ Failure Assessment score; SEPSIS-1 severe sepsis: 
 SEPSIS-1 SEPSIS-3 qSOFA≥2 SEPSIS-1 
severe sepsis 
NEWS≥6 
Sensitivity, % 
(95%CI) 
68 (56-78) 86 (76-92) 22 (14-33) 92 (83-97) 41 (30-53) 
Specificity, % 
(95%CI) 
47 (41-53) 32 (27-38) 89 (85-92) 24 (19-29) 73 (67-77) 
Positive 
predictive 
value, % 
(95%CI) 
25 (19-31) 25 (20-30) 34 (22-49) 24 (19-29) 30 (26-35) 
Negative 
predictive 
value, % 
(95%CI) 
85 (78-90) 90 (82-95) 82 (77-85) 92 (83-97) 70 (65-74) 
Positive 
likelihood 
ratio (95%CI) 
1.28 (1.06-
1.54) 
1.27 (1.13-
1.43) 
1.99 (1.17-
3.39) 
1.21 (1.11-
1.33) 
1.49 (1.08-
2.06) 
Negative 
likelihood 
ratio (95%CI) 
0.68 (0.49-
0.95) 
0.43 (0.25-
0.76) 
0.88 (0.78-
0.99) 
0.32 (0.15-
0.71) 
0.81 (0.67-
0.98) 
 30 
sepsis with organ dysfunction as defined by Bone et al. (6); NEWS: National 
Early Warning Score 
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Figure legends 
Fig 1. Organisational flowchart of the study 
207 patients gave consent on the day, 66 patient representatives gave assent 
and 107 patients were entered following professional assent. 51 patients (46 
patients and 5 patient representatives) refused participation and no data was 
collected. 
Fig 2. Patients identified having sepsis using the SEPSIS-1 and SEPSIS-3 
clinical criteria 
 
 SOFA: Sequential organ failure assessment score; SIRS: systemic 
inflammatory response syndrome criteria; qSOFA: quick Sequential organ 
failure assessment score; SEPSIS-1 is defined by SIRS≥2. SEPSIS-3 is defined 
by SOFA≥2 and/or qSOFA≥2. 44 patients did not fulfill either SEPSIS-1 or 
SEPSIS-3 criteria.  
 
 
Fig 3. Distribution of SEPSIS-1 and SEPSIS-3 clinical criteria in patients who 
died within 30 days (n=78) 
 
 SOFA: Sequential organ failure assessment score; SIRS: systemic 
inflammatory response syndrome criteria; qSOFA: quick Sequential organ 
failure assessment score; SEPSIS-1 is defined by SIRS≥2. SEPSIS-3 is defined 
by SOFA≥2 and/or qSOFA≥2. One patient did not fulfill either SEPSIS-1 or 
SEPSIS-3 criteria. 
 
Fig 4. Survival difference of patients with different definitions of sepsis 
 
Not meeting any sepsis criteria (black solid line), SEPSIS-1 definition (yellow 
dotted line), SEPSIS-3 definition (blue dashed line), both SEPSIS-1 and SEPSIS-
3 definition (red dashed line with dots), * p=0.015 
